Timing of Bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity

DOI: 10.4244/EIJ-D-22-00644

David Meier
David Meier1,2,3, MD; Geoffrey W. Payne4, MSc, PhD; Leila B. Mostaço-Guidolin5, PhD; Rihab Bouchareb6, MSc, PhD; Courtney Rich7, BASc; Althea Lai2, BSc; Andrew G. Chatfield1,2, MB ChB; Mariama Akodad1,2,3; Hannah Salcudean, MSc; Georg Lutter8,9, MD; Thomas Puehler8,9, MD; Philippe Pibarot10, DVM, PhD; Keith B. Allen11, MD; Adnan K. Chhatriwalla11, MD; Lars Sondergaard12, MD; David A. Wood1,3, MD; John G. Webb1,3, MD; Jonathon A. Leipsic3, MD; Janarthanan Sathananthan1,2,3, MPH, MBChB; Stephanie L. Sellers1,2,3, MSc, PhD
1. Centre for Cardiovascular Innovation, University of British Columbia, St Paul’s and Vancouver General Hospital, Vancouver, Canada; 2. Cardiovascular Translational Laboratory, Providence Research & Centre for Heart Lung Innovation, Vancouver, Canada; 3. Centre for Heart Valve Innovation, St. Paul’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada; 4. University of Northern British Columbia, Prince George, Canada; 5. Systems and Computer Engineering, Carleton University, Ottawa, Canada; 6. Mount Sinai Icahn School of Medicine; 7. ViVitro Labs Inc., Victoria, British Columbia, Canada; 8. Department of Cardiac and Vascular Surgery, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany; 9. DZHK (German Centre for Cardiovascular Research), partner site Kiel/Hamburg, Germany; 10. Québec Heart and Lung Institute, Department of Medicine, Laval University, Québec, Canada; 11. Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri, USA; 12. Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention and external reviewers - has been published immediately upon acceptance as it was received in the last round of revision. The content of this article is the responsibility of the authors.

Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.

To read the full content of this article, please download the PDF.

Download full article (PDF)

Abstract

Background: BVF can be used to improve THV hemodynamics following valve-in-valve (VIV) intervention. However, whether BVF should be performed before or after THV deployment and implications on durability is unknown. Aims: To assess the impact of bioprosthetic valve fracture (BVF) timing on long-term transcatheter heart valve (THV) durability. Methods : The impact of BVF timing was assessed using small ACURATE neo (ACn) or 23mm SAPIEN 3 (S3) THVs deployed in 21mm Mitroflow valves compared to no-BVF controls. Valves underwent accelerated wear testing (AWT) up to 200M cycles (equivalent to 5 years). At 200M cycles, THVs were evaluated by hydrodynamic testing, second harmonic generation (SHG) microscopy, scanning electron microscopy (SEM) and histology. Results: At 200M cycles, the regurgitant fraction (RF) and effective orifice area (EOA) for the ACn were respectively 8.03±0.30%/1.74±0.01cm 2 (no BVF), 12.48±0.70%/1.97±0.02cm 2 (BVF before VIV) and 9.29±0.38%/2.21±0.0cm 2 (BVF after VIV). For the S3 these values were 2.63±0.51%/1.26±0.01cm 2 , 2.03±0.42%/1.65±0.01cm 2 , and 1.62±0.38%/2.22±0.01cm 2 respectively. Further, SHG and SEM revealed a higher degree of superficial leaflet damage when BVF was performed after VIV for ACn and S3. However, histological analysis, revealed significantly less damage, determined by matrix density analysis, through the entire leaflet thickness when BVF was performed after VIV with the S3 and a similar but non-significant trend in ACn. Conclusion: BVF performed after VIV appears to offer superior long-term EOA without increased RF. Ultra-structure leaflet analysis reveals that timing of BVF can differentially impact leaflets, with more superficial damage but greater preservation of overall leaflet structure when BVF is performed after VIV.

Supplementary data

  • To read the full content of this article, along with its supplementary data, please download the PDF
Read next article
Acute Outcomes for the Full US Cohort of the FLASH Mechanical Thrombectomy Registry in Pulmonary Embolism

Latest news